An American multinational computer technology corporation was interested in enteringthe clinical trial software market. The main objective of the research was to track developments in the global clinical trial softwaremarket. The client was primarily interested in market data about recent advancements in AI-enabled robotics and total investments in this area. The company was also looking for the year-on-year growth of this technology and its adoption regionally.
The study was conducted in several phases, which are briefly discussed below.
Our research team studied the market dynamics, including drivers, restraints, opportunities, and ongoing trends, through exhaustive secondary research to gain a clear market understanding of the various initiatives undertaken by market players.
Based on the data collected from secondary research, we conducted a company market share analysis based on thetechnical features of the software, price, strategic initiatives by the market player, technological platform, and financial performance.
We provided basic data on the prices of various available clinical trial software solutions in the market. We also provided data on recent advancements in the area of clinical trial management software. Our research also helped the client understand the price differenceamong the available software.
Our report on clinical trial management software helped the client in understanding the existing competition and new entrants' marketing strategies. The data also helped the client in determining competitive pricing for its potential clinical trial software.